Literature DB >> 8605180

Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.

P A Raj1, E Marcus, M Edgerton.   

Abstract

Bactenecin 5 and its fragments [BN22 (1-22), BN16 (7-22), and BC24 (20-43)] were synthesized by solid-phase methods. Their antifungal activities on Candida albicans have been studied and compared with those of the native bactenecin 5. The conformational preferences of these peptides in aqueous and nonaqueous solutions and in lipid vesicles were examined by circular dichroism. The highly active N-terminal fragment (BN16) was examined in aqueous solution using 500 MHz two-dimensional NMR. Bactenecin 5 and its fragments are potent candidacidal agents against C. albicans. The N-terminal fragments (BN22 and BN16) of bactenecin 5 are relatively more active than the C-terminal fragment BC24, especially at lower concentrations. The N-terminal region (7-22) which retains the activity of the whole molecule appears to be the functional domain for candidacidal activity. The CD spectra of bactenecin 5 and its fragments are reminiscent of the CD spectrum of poly(L-proline) type II structure in aqueous and nonaqueous solutions and also in lipid vesicles. The temperature dependence of NH chemical shifts and 1H/2H exchange effect on amide resonances suggest the absence of intramolecularly hydrogen-bonded NH groups. The coupling constant (JNH-CalphaH) values, conformational restriction offered by the Pro residues (phi = -60 degrees +/- 15 degrees), the set of medium- and short-range nuclear Overhauser effects observed for the active N-terminal fragment (BN16), and the restrained structure calculation using DIANA suggest that poly(L-proline) type II conformers of the peptide molecules could be significantly populated in aqueous solution. The ability of bactenecin peptides to induce disruption of lipid vesicles correlates well with their activity. Our results suggest that poly(L-proline) type II structure may, indeed, be the biologically active conformation for candidacidal activity of bactenecin peptides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605180     DOI: 10.1021/bi951681r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.

Authors:  Slavena Vylkova; Xuewei S Li; Jennifer C Berner; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes.

Authors:  O Shamova; K A Brogden; C Zhao; T Nguyen; V N Kokryakov; R I Lehrer
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

3.  Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans.

Authors:  S E Koshlukova; M W Araujo; D Baev; M Edgerton
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 4.  Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action.

Authors:  Marco Scocchi; Alessandro Tossi; Renato Gennaro
Journal:  Cell Mol Life Sci       Date:  2011-05-19       Impact factor: 9.261

Review 5.  Diversity in penaeidin antimicrobial peptide form and function.

Authors:  Brandon J Cuthbertson; Leesa J Deterding; Jason G Williams; Kenneth B Tomer; Kizee Etienne; Perry J Blackshear; Erika E Büllesbach; Paul S Gross
Journal:  Dev Comp Immunol       Date:  2007-08-03       Impact factor: 3.636

6.  In vitro and in vivo properties of the bovine antimicrobial peptide, Bactenecin 5.

Authors:  R L Price; L Bugeon; S Mostowy; C Makendi; B W Wren; H D Williams; S J Willcocks
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

7.  New phosphated poly(methyl methacrylate) polymers for the prevention of denture-induced microbial infection: an in vitro study.

Authors:  Periathamby Antony Raj; Andrew R Dentino
Journal:  Clin Cosmet Investig Dent       Date:  2011-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.